Clinical trials located in


Niort city is located in France. Currently, 1 clinical trials are being conducted in this city.

Niort, nestled in western France, is the capital of the Deux-Sèvres department. This city is renowned for its medieval heritage, notably the imposing Donjon de Niort, a pair of twin castles dating back to the 12th century. Niort is also a financial hub, home to several major insurance companies. The city is cradled by the Sèvre Niortaise River, enhancing its picturesque landscape. Niort’s vibrant market, Les Halles, showcases the region’s gastronomic richness, offering local specialties. Additionally, Niort serves as a gateway to the Marais Poitevin, an expansive marshland known as “Green Venice” for its verdant, waterlogged channels.

  • CT-EU-00115994

    Exploring a new treatment combination for rheumatoid arthritis: baricitinib plus anti-TNF

    This clinical trial is focused on finding a more effective treatment for people with Rheumatoid Arthritis (RA) who haven’t responded well to previous therapies. The study is comparing two different approaches: one group will receive a combination of baricitinib treatment and an anti-TNF therapy (adalimumab), while the other group will receive baricitinib along with a placebo. The main goal is to see which group shows a greater improvement in their RA symptoms, specifically looking for a 50% improvement in symptoms, known as an ACR 50 response, after 24 weeks from the start of the treatment.

    Baricitinib is a medication that targets certain pathways in the body’s immune system to reduce inflammation and pain in RA. Anti-TNF therapy, like adalimumab, works by blocking the action of a protein in the body that causes inflammation. By combining these two treatments, researchers hope to see a more significant improvement in RA symptoms than with baricitinib alone.

    The trial is important because it aims to provide a new option for patients with RA who have not found relief with current treatments. It’s designed to test the safety and effectiveness of using these two different types of medications together.

    • placebo
    • Adalimumab
    • Baricitinib

See more clinical trials in other cities in France: